脑部放疗，上午比下午敏感许多！
3 N/ c9 C: c6 l4 u* Q& z4 g: N: Z8 m" U8 z7 G- _) e* Z
v* c- z0 x1 G" A% W" a6 bCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
" O5 C7 g- E; q5 ^ w9 s" sGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
# H# X* K8 \9 s+ \Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.1 r, k' K7 u4 p# `* S/ c9 ] d8 a
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA./ D$ ]* P; U( [6 _/ j s4 a
% X+ |# a% H# E; ?3 y) Z% X3 ? \
Abstract0 w- o: C1 \3 M& M: j9 @
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.) o3 @) S$ t- f
1 [2 R1 B/ o. ~- |) }7 j* C- R' p. ZMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
, B4 a: w8 {1 s. s
V0 I. F P9 WRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
# v& K; B6 I% ]9 ?3 H6 J$ g! N$ y- d+ [( i" d9 ?4 q. e) c
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.8 E' b R& h% S- O) x
) m+ u, l' A4 X4 u g! c |
11011102001537 )
2 N- c/ c# W5 t: u1 O
显身卡
